Does pioglitazone affect the development of acute pancreatitis and HSP70 expression in a cerulein-induced model?
Pioglitazone demonstrates protective effects against acute pancreatitis in a preclinical cerulein-induced model.
To determine the effect of pioglitazone, a specific peroxisome proliferator-activated receptor- (PPAR) ligand, on the development of acute pancreatitis (AP) and on the expression of heat shock protein 70 (HSP70) in the pancreas.
Peter C. Konturek (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: